Latest Breaking News On - Exsurgo axon - Page 4 : vimarsana.com

Press Release – Exsurgo A recent UK study has confirmed the exciting potential of a breakthrough treatment for chronic pain management developed by New Zealand neuroscience company, Exsurgo. Chronic pain (defined as pain that persists for longer than three months) affects … A recent UK study has confirmed the exciting potential of a breakthrough treatment for chronic pain management developed by New Zealand neuroscience company, Exsurgo. Chronic pain (defined as pain that persists for longer than three months) affects up to 1 in 5 people around the world and is a massive burden on healthcare systems and economies. A 2018 report commissioned by the Australian and New Zealand College of Anaesthetists (ANZCA) estimated the total annual cost to New Zealand of chronic pain at $13-14.9 billion – greater than those for diabetes, dementia and smoking.[1]

New zealandUnited kingdomExsurgo axonChristine ozolinsZealand college of anaesthetistsPress releaseNew zealand collegeConsultant spinal specialistEast midlands spine ltdPrincipal investigatorClinical advisorChief science officer christine ozolinsNew zealandபுதியது ஜீலாந்துஒன்றுபட்டது கிஂக்டம்ஜீலாந்து கல்லூரி ஆஃப் மயக்க மருந்து நிபுணர்கள்